 | • レポートコード：MRC2303K082 • 出版社/出版日：Mordor Intelligence / 2023年2月 • レポート形態：英文、PDF、110ページ • 納品方法：Eメール（受注後2-3営業日） • 産業分類：医療機器 |
| Single User | ￥712,500 (USD4,750) | ▷ お問い合わせ |
| Corporate License | ￥1,312,500 (USD8,750) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| Mordor Intelligence社の調査レポートでは、世界のヘルニアメッシュ機器市場規模が、予測期間中、CAGR 4.3％で増大すると予測されています。本レポートでは、ヘルニアメッシュ機器の世界市場を広く調査・分析し、イントロダクション、調査手法、エグゼクティブサマリー、市場動向、ヘルニア種類別（鼠径ヘルニア、瘢痕ヘルニア、大腿ヘルニア、その他）分析、メッシュ種類別（生物学的メッシュ、合成繊維メッシュ）分析、メッシュ素材別（吸収性メッシュ、非吸収性メッシュ）分析、エンドユーザー別（病院、外来手術センター、診療所）分析、地域別（アメリカ、カナダ、メキシコ、ドイツ、イギリス、フランス、イタリア、スペイン、中国、日本、インド、オーストラリア、韓国、中東、南アフリカ、ブラジル、アルゼンチン）分析、競争状況、市場機会・将来動向などについて調査・分析などの項目を掲載しています。並び、こちらのレポートには、Medtronic Plc、Ethicon Inc.、B. Braun SE、Becton, Dickinson and Co.、W. L. Gore & Associates, Inc.、AbbVie Inc.、Getinge AB.、Cook Medical、Integra LifeSciences、Dipromed Srlなどの企業情報が含まれています。 ・イントロダクション ・調査手法 ・エグゼクティブサマリー ・市場動向 ・世界のヘルニアメッシュ機器市場規模：ヘルニア種類別 - 鼠径ヘルニアにおける市場規模 - 瘢痕ヘルニアにおける市場規模 - 大腿ヘルニアにおける市場規模 - その他ヘルニアにおける市場規模 ・世界のヘルニアメッシュ機器市場規模：メッシュ種類別 - 生物学的メッシュの市場規模 - 合成繊維メッシュの市場規模 ・世界のヘルニアメッシュ機器市場規模：メッシュ素材別 - 吸収性メッシュの市場規模 - 非吸収性メッシュの市場規模 ・世界のヘルニアメッシュ機器市場規模：エンドユーザー別 - 静脈注射における市場規模 - 皮下注射における市場規模 - 経口における市場規模 ・世界のヘルニアメッシュ機器市場規模：地域別 - 北米のヘルニアメッシュ機器市場規模 アメリカのヘルニアメッシュ機器市場規模 カナダのヘルニアメッシュ機器市場規模 メキシコのヘルニアメッシュ機器市場規模 … - ヨーロッパのヘルニアメッシュ機器市場規模 ドイツのヘルニアメッシュ機器市場規模 イギリスのヘルニアメッシュ機器市場規模 フランスのヘルニアメッシュ機器市場規模 … - アジア太平洋のヘルニアメッシュ機器市場規模 中国のヘルニアメッシュ機器市場規模 日本のヘルニアメッシュ機器市場規模 インドのヘルニアメッシュ機器市場規模 … - 南米/中東のヘルニアメッシュ機器市場規模 南アフリカのヘルニアメッシュ機器市場規模 ブラジルのヘルニアメッシュ機器市場規模 アルゼンチンのヘルニアメッシュ機器市場規模 … ・競争状況 ・市場機会・将来動向 |
The hernia mesh devices market is expected to register a CAGR of 4.3% over the forecast period.
Due to the sudden implementation of stringent lockdowns throughout the world during the pandemic, COVID-19 had a substantial impact on the market’s growth. Additionally, due to the primary focus on emergency COVID-19 treatments, there were fewer patient visits, and hernia surgeries were postponed, leading to complications in patients suffering from hernias. For instance, according to the article published by National Center for Biotechnology Information (NCBI) in September 2022, the onset of the pandemic resulted in a reduction in the number of elective hernia surgeries, mainly the incisional hernia surgery, with the first three months of lockdown having the most significant impact. However, due to the gradual lifting of COVID-19 restrictions after May 2020, there was a surge in the number of inguinal hernia surgeries. For instance, as per the study published by NCBI in May 2022, approximately 43.0% of the patients endured inguinal hernia repair surgeries, 6.6% experienced incarceration, and 15.2% had an emergency department encounter during the post-cancellation period. Thus, the COVID-19 outbreak affected the market’s growth adversely in its preliminary phase; however, the market is expected to gain traction due to the significant increase in the number of hernia repair surgeries globally.
The high prevalence of hernia all over the world, the surging number of surgeries being performed for the treatment of hernias, and the employment of biomaterials in three-dimensional mesh development are among the major factors driving the growth of the market studied. For instance, according to the National Center for Health Statistics report 2022, more than five million people in the United States suffer from hernia every year. The major factors causing hernia are the high geriatric population, constipation, chronic cough due to smoking, and high premature birth rates. In addition, in recent years, there has been a surge in the number of surgeries performed to treat hernia. For instance, according to the article published in NCBI in August 2022, inguinal hernia is the most commonly occurring type of hernia and over 800,000 inguinal hernia surgeries are performed every year in the United States. Such factors are likely to boost the adoption of hernia mesh devices, thereby contributing to the market studied’s growth.
Moreover, in the recent few years, there has been a surge in the employment of different biodegradable polymers for the development of three-dimensional meshes for hernia treatment. For instance, as per the article published in NCBI in February 2022, numerous biodegradable polymers are used to create medical devices, including implants and three-dimensional meshes. The bioactive and biocompatible qualities of biodegradable polymers, when combined with next-generation technologies and cell-based therapies, can advance tissue regeneration and the healing of damaged or injured tissue. Therefore, the adoption of biomaterials for three-dimensional mesh development is expected to accelerate the hernia mesh devices market globally and to increase in the future, thereby driving the growth of the market studied over the forecast period.
Hernia Mesh Devices Market Trends
Biologic Mesh Segment is Expected to Witness Significant Growth Over the Forecast Period
Biologic mesh is mainly developed from the porcine or human dermis. It offers several advantages over synthetic ones, including its high ability to be used in a contaminated area without the fear of infection. For instance, as per the article published in the American Society of Plastic Surgeons Wolters Kluwer Health, Inc. in February 2022, the synthetic meshes used for ventral hernia repair treatment led to several infections at the surgical site, fistula formation, abdominal stiffness, and adhesion. In order to address these issues, biological meshes were developed. More recently, they have been strongly recommended for use when infection risk is elevated, and contamination levels are high. Thus, due to the several benefits associated with the aid of biological meshes over synthetic ones, the segment is expected to register high growth during the forecast period.
Additionally, the recurrence rate of hernia is significantly less with the use of reinforced biologic ovine rumen (RBOR) mesh compared to the other types, leading to its high adoption while performing hernia surgeries. For instance, as per the study published in NCBI in February 2022, the risk of complications and hernia recurrence was higher in patients receiving cross-linked porcine acellular dermal matrices (C-PADM) mesh, i.e., 52.9%, in comparison to the ones receiving reinforced biologic ovine rumen (RBOR), i.e., only 16.7%. Thus, the adoption of RBOR for hernia treatment is augmenting the segment growth.
North America is Expected to Dominate the Hernia Mesh Devices Market
North America is expected to dominate the market owing to factors such as the high prevalence of hernias, the high number of hernia repair surgeries being performed in the region, and the adoption of machine learning models in the United States for the prediction of adverse events. As per the American College of Surgeons (ACS) in April 2022, in the United States, there are four million abdominal procedures performed annually, some of which may require hernia repair. Thus, the high number of hernia repair surgeries being performed in the region is expected to drive regional growth during the forecast period.
In addition, the adoption of ML models for the prediction of hernia recurrence in the United States is also burgeoning the regional market growth. For instance, in April 2022, the University of Texas MD Anderson Cancer Center announced the launch of an ML model, which can easily predict hernia recurrence and other complications post-surgery. In the patients who had been through ventral hernia surgery, the ML model showed the following accuracy rates: 85% for forecasting hernia recurrence, 72% for forecasting surgical site occurrence, and 84% for forecasting 30-day hospital readmission. Thus, the surgical number of hernia incidence and adoption of advanced models is expected to drive the demand for hernia mesh devices market in the region.
Therefore, owing to the aforesaid factors the growth of the studied market is anticipated in the North America Region.
Hernia Mesh Devices Market Competitor Analysis
The hernia mesh devices market is fragmented due to the presence of several companies operating globally and regionally. The competitive landscape includes an analysis of a few international as well as local companies which hold the market shares and are well known, including Medtronic Plc, Ethicon Inc., B. Braun SE, Becton, Dickinson and Co., W. L. Gore & Associates, Inc., AbbVie Inc., Getinge AB., Cook Medical, Integra LifeSciences, Dipromed SRL, among others.
Additional Benefits:
- The market estimate (ME) sheet in Excel format
- 3 months of analyst support
1 INTRODUCTION
1.1 Study Assumptions and Market Definition
1.2 Scope of the Study
2 RESEARCH METHODOLOGY
3 EXECUTIVE SUMMARY
4 MARKET DYNAMICS
4.1 Market Overview
4.2 Market Drivers
4.2.1 Surging Adoption of Mesh in Hernia Repair
4.2.2 Increasing Prevalence of Hernia
4.2.3 Technological Advancements in Mesh
4.3 Market Restraints
4.3.1 High Cost of Meshes
4.3.2 Presence of Substitutes in Hernia Mesh Devices
4.4 Porter’s Five Forces Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry
5 MARKET SEGMENTATION (Market Size by Value – USD million)
5.1 By Hernia Type
5.1.1 Inguinal Hernia
5.1.2 Incisional Hernia
5.1.3 Femoral Hernia
5.1.4 Other Hernia Types
5.2 By Mesh Type
5.2.1 Biologic Mesh
5.2.2 Synthetic Mesh
5.3 By Mesh Material
5.3.1 Absorbable Mesh
5.3.2 Non-Absorbable Mesh
5.4 By End-User
5.4.1 Hospitals
5.4.2 Ambulatory Surgical Centers
5.4.3 Clinics
5.5 By Geography
5.5.1 North America
5.5.1.1 United States
5.5.1.2 Canada
5.5.1.3 Mexico
5.5.2 Europe
5.5.2.1 Germany
5.5.2.2 United Kingdom
5.5.2.3 France
5.5.2.4 Italy
5.5.2.5 Spain
5.5.2.6 Rest of Europe
5.5.3 Asia-Pacific
5.5.3.1 China
5.5.3.2 Japan
5.5.3.3 India
5.5.3.4 Australia
5.5.3.5 South Korea
5.5.3.6 Rest of Asia-Pacific
5.5.4 Middle East
5.5.4.1 GCC
5.5.4.2 South Africa
5.5.4.3 Rest of Middle East
5.5.5 South America
5.5.5.1 Brazil
5.5.5.2 Argentina
5.5.5.3 Rest of South America
6 COMPETITIVE LANDSCAPE
6.1 Company Profiles
6.1.1 Medtronic Plc
6.1.2 Ethicon Inc.
6.1.3 B. Braun SE
6.1.4 Becton, Dickinson and Co.
6.1.5 W. L. Gore & Associates, Inc.
6.1.6 AbbVie Inc.
6.1.7 Getinge AB.
6.1.8 Cook Medical
6.1.9 Integra LifeSciences
6.1.10 Dipromed Srl
7 MARKET OPPORTUNITIES AND FUTURE TRENDS